![](/img/cover-not-exists.png)
Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial
Guy Amit, Carlos Cafri, Sergei Yaroslavtsev, Shmuel Fuchs, Ora Paltiel, Akram Abu-Ful, Jean M. Weinstein, Arik Wolak, Reuben Ilia, Doron ZahgerVolume:
152
Year:
2006
Language:
english
Pages:
65535
DOI:
10.1016/j.ahj.2006.05.010
File:
PDF, 162 KB
english, 2006